|
Jun 17
|
AIM ImmunoTech Resumes Trading on NYSE American
|
|
Feb 11
|
AIM ImmunoTech Releases Virtual Investor “What This Means Segment”
|
|
Feb 11
|
AIM ImmunoTech announces that it will not proceed with an offering pursuant to its Registration Statement on Form S-1 until after it files its Annual Report on Form 10-K for the fiscal year ended December 31, 2024
|